We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

AI Used to Successfully Treat Metastatic Cancer Patient

News   Sep 03, 2018 | Original story from the National University of Singapore

 
AI Used to Successfully Treat Metastatic Cancer Patient

Professor Dean Ho (left) and Mr Theodore Kee (right) from the National University of Singapore, together with their translational research team, harnessed CURATE.AI to successfully treat a patient with advanced cancer, completely halting disease progression. Credit: National University of Singapore

 
 
 

RELATED ARTICLES

Study Finds Commercially Available Antibodies Are Not Binding Their Target

News

In a new study, researchers have tested the binding specificity of commercial antibodies to the C9ORF72 protein, and explored a novel validation approach.

READ MORE

Will a Next-generation Therapy for Diabetes Soon Be Available?

News

In order to improve diabetes therapy, researchers at the University of Geneva (UNIGE), Switzerland, have identified a protein called S100A9 which, under certain conditions, seems to act as a blood sugar and lipid regulator while avoiding the most harmful side effects of insulin.

READ MORE

Personalized Immunotherapy Refined by Mass Spec-Machine Learning Pairing

News

A combination of mass spectrometry and a novel computational tool is more accurately identifying the molecular signs of cancer likely to be presented to helper T cells, which stimulate and orchestrate the immune response to tumors and infectious agents.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Drug Discovery Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE